Ask Warren

From Bio

377220 · KOSDAQ · ₩377220 · 프롬바이오

₩1,929▼ ₩166 (7.92%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −73.61%
Market cap
₩11B
Enterprise value
₩12B
P/E
—
P/B
0.5×
Dividend yield
0.0%
ROE
−86.8%
Net margin
−28.1%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−80.4% from the high

₩1,750Today: ₩1,820 – ₩2,205₩9,865

Returns

  • 1W−21.9%
  • 1M−22.4%
  • 3M−24.8%
  • 6M−70.0%
  • YTD−68.8%
  • 1Y−73.6%
Volume today
248,700
0.6× the 20-day average
Traded today
₩484M
Listed shares
5,662,000
EPS (12 months)
−₩3,556
Earnings yield −184.3%
SellBuy
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

XfWATGr/in@

Why is it moving?

−7.9% on Oct 27, 2026.

From Bio has filed notice of a shareholders' meeting. This is a routine corporate filing and does not say much about the company's current situation.

AI summary of the news and filings linked. It can be wrong; check them.

Possible reasons, not certainties. Not financial advice.

Signals

34Quiet
  • BuzzQuietBuzz 34 of 100 (50 is a normal day for this stock).
  • SentimentMixedNews: Routine filing with no clear positive or negative content. Community: 0 bullish, 0 bearish posts this week.
  • MomentumWeak-28.7% over the last month; the price is below its 20-day average.
  • News impactLow2 news items and filings in two weeks; 0 rated high impact, 0 medium.

Signals describe activity, not recommendations. Not financial advice.

From Bio stock overview

From Bio (프롬바이오, KRX: 377220) is listed on KOSDAQ, in the Food & Beverage sector. Promit Bio is a Korean company that runs the full value chain of health functional foods, from target product selection and raw material sourcing to functional ingredient development, manufacturing, distribution and sales. Its shares closed at ₩1,929 on Oct 27, 2026, down 7.92% on the day, giving it a market value of ₩11B.

Key facts

Market cap
₩11B
Sector
Food & Beverage
Latest price change
−7.92%
As of
Oct 27, 2026
Main business
Promit Bio is a Korean company that runs the full value chain of health functional foods, from target product selection and raw material sourcing to functional ingredient development, manufacturing, distribution and sales.

Quick answers about From Bio

What does From Bio do?
Promit Bio is a Korean company that runs the full value chain of health functional foods, from target product selection and raw material sourcing to functional ingredient development, manufacturing, distribution and sales. Its main products are health supplements built on individually recognized functional raw materials such as boswellia extract and mastic gum, sold mainly domestically through TV home shopping, online channels and offline retail. Through its subsidiary Promit Bio Cosmetic it also sells cosmetics, and it conducts cell culture and stem cell research.
What is the market cap of From Bio?
The market capitalisation of From Bio was ₩11B at the close on Oct 27, 2026.
Who are the largest shareholders of From Bio?
According to the latest official filings, the largest reported holders are Shim Tae-jin (41.34%, as of Sep 18, 2026); Hong In-gi (0.01%, as of Apr 3, 2025).
When is the next earnings report from From Bio?
Korean companies rarely announce results dates in advance. Based on when From Bio filed the same report in past years, its next 3q results is expected around Nov 14, 2026.

Company profile

Promit Bio is a Korean company that runs the full value chain of health functional foods, from target product selection and raw material sourcing to functional ingredient development, manufacturing, distribution and sales. Its main products are health supplements built on individually recognized functional raw materials such as boswellia extract and mastic gum, sold mainly domestically through TV home shopping, online channels and offline retail. Through its subsidiary Promit Bio Cosmetic it also sells cosmetics, and it conducts cell culture and stem cell research.

Written by AI from the company's latest annual report.

Korean name
프롬바이오
Sector
Food & Beverage
Themes
Semiconductor equipment & materialsBiotech (new drugs)
CEO
심태진
Founded
Jun 2006
Listed
Sep 2021
Listed shares
5,662,000
Fiscal year ends
Month 12
Website
frombio-company.co.kr

Similar companies

Recent news

News · Chosun Biz·

[Exclusive] Pharma Company 'Health Supplement Leader' PromBio Pursues Management Rights Sale... Hair Loss Drug Reversal Failed to Work

From Bio₩1,929▼7.92%
Read the original ↗

Predicted impact: Medium· Actual: +28.1% vs sector, volume 23.3× normal (5 trading days)

Exclusive report of management rights sale at a very small company; deal size unknown but could be material.

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: From Bio / 프롬바이오 / 377220 / KRX:377220

Source: KRX statistical information